PhRMA dues fell almost $100 million as major drugmakers exited
Chief Washington Correspondent Rachel Cohrs Zhang reports on the intersection of health policy and business in Washington. She covers Capitol Hill, lobbying, and federal agencies.
Chief Washington Correspondent Rachel Cohrs Zhang reports on the intersection of health policy and business in Washington. She covers Capitol Hill, lobbying, and federal agencies.
WASHINGTON — In Congress, end-of-year government spending packages adorned with numerous other priorities attached are called “Christmas tree” bills. This year, the health care policy
WASHINGTON — House Republicans have abandoned an effort to include reforms to pharmacy benefit managers in an end-of-year bill to fund the federal government. Congressional leaders
WASHINGTON — After two years of haggling, Congress has nearly reached a deal to rein in the drug-industry middlemen known as pharmacy benefit managers. Lawmakers
Chief Washington Correspondent Rachel Cohrs Zhang reports on the intersection of health policy and business in Washington. She covers Capitol Hill, lobbying, and federal agencies.
WASHINGTON — Negotiations over a large health care policy package are heating up this week as Congress hurtles toward a government funding deadline at the end
WASHINGTON — Scott Gottlieb, who served as Food and Drug Administration commissioner in the first Trump administration, is raising concerns with Senate Republicans about the
President-elect Trump has chosen Stanford University professor Jay Bhattacharya to lead the National Institutes of Health, his transition announced Tuesday. If confirmed by the Senate,
WASHINGTON — The Biden administration is proposing a major expansion of how Medicare and Medicaid cover the blockbuster weight-loss drugs Wegovy and Zepbound, the White
WASHINGTON — Johns Hopkins surgeon Marty Makary has criticized – sometimes with harsh language – the Food and Drug Administration that President-elect Trump has tapped